Calpain 8/nCL-2 and Calpain 9/nCL-4 Constitute an Active Protease Complex, G-Calpain, Involved in Gastric Mucosal Defense by Hata, Shoji et al.
Calpain 8/nCL-2 and Calpain 9/nCL-4 Constitute an
Active Protease Complex, G-Calpain, Involved in Gastric
Mucosal Defense
Shoji Hata
1, Manabu Abe
2, Hidenori Suzuki
3, Fujiko Kitamura
1, Noriko Toyama-Sorimachi
4, Keiko Abe
5,
Kenji Sakimura
2, Hiroyuki Sorimachi
1,6*
1Calpain Project, The Tokyo Metropolitan Institute of Medical Science (Rinshoken), Tokyo, Japan, 2Department of Cellular Neurobiology, Brain Research Institute, Niigata
University, Niigata, Japan, 3Laboratory of Electron Microscopy, The Tokyo Metropolitan Institute of Medical Science (Rinshoken), Tokyo, Japan, 4Department of
Gastroenterology, National Center for Global Health and Medicine, Tokyo, Japan, 5Department of Agricultural and Life Sciences, The University of Tokyo, Tokyo, Japan,
6Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency (JST), Kawaguchi, Japan
Abstract
Calpains constitute a superfamily of Ca
2+-dependent cysteine proteases, indispensable for various cellular processes. Among
the 15 mammalian calpains, calpain 8/nCL-2 and calpain 9/nCL-4 are predominantly expressed in the gastrointestinal tract and
are restricted to the gastric surface mucus (pit) cells in the stomach. Possible functions reported for calpain 8 are in vesicle
trafficking between ER and Golgi, and calpain 9 are implicated in suppressing tumorigenesis. These highlight that calpains 8
and 9 are regulated differently from each other and from conventional calpains and, thus, have potentially important, specific
functions in the gastrointestinal tract. However, there is no direct evidence implicating calpain 8 or 9 in human disease, and
theirpropertiesandphysiologicalfunctionsarecurrentlyunknown.Toaddresstheirphysiologicalroles,weanalyzedmicewith
mutations in the genes for these calpains, Capn8 and Capn9. Capn8
2/2 and Capn9
2/2 mice were fertile, and their gastric
mucosae appeared normal. However, bothmice were susceptible to gastric mucosalinjury induced by ethanol administration.
Moreover, the Capn8
2/2 stomach showed significant decreases in both calpains 9 and 8, and the same was true for Capn9
2/2.
Consistent with this finding, in the wild-type stomach, calpains 8 and 9 formed a complex we termed ‘‘G-calpain,’’ in which
both were essential for activity. This is the first example of a ‘‘hybrid’’ calpain complex. To address the physiological relevance
of the calpain 8 proteolytic activity, we generated calpain 8:C105S ‘‘knock-in’’ (Capn8
CS/CS) mice, which expressed a
proteolytically inactive, but structurally intact, calpain 8. Although, unlike the Capn8
2/2 stomach, that of the Capn8
CS/CS mice
expressed a stable and active calpain 9, the mice were susceptible to ethanol-induced gastric injury. These results provide the
first evidence that both of the gastrointestinal-tract-specific calpains are essential for gastric mucosal defense, and they point
to G-calpain as a potential target for gastropathies caused by external stresses.
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Introduction
Calpain (Clan CA-C2, EC 3.4.22.17) is a family of intracellular
Ca
2+-regulated cysteine proteases found in almost all eukaryotic
and some bacterial, and all the members of this family share
homology in the protease domain [1,2]. Calpains play indispens-
able roles in biological processes including the cell cycle, apoptosis,
platelet aggregation, and myoblast fusion, through the limited
proteolytic cleavage of diverse substrates. Improper calpain
activity often causes death or serious disorders, such as muscular
dystrophies or lissencephaly [3–8].
The mammalian calpains include both ubiquitous and tissue-
specific members [2]. The gastrointestinal-tract (GI) expresses two
major ubiquitous calpains, m- and m-calpain, and two GI-specific
ones, calpain 8/nCL-2 and calpain 9/nCL-4 [9,10]. The m- and
m-calpains each form a heterodimer consisting of a distinct 80-
kDa catalytic subunit (calpain 1/mCL and calpain 2/mCL,
respectively) and a common 30-kDa regulatory subunit
(CAPNS1/30K), which acts as a molecular chaperone for calpains
1 and 2. Calpains 8 and 9 have a typical domain structure like that
of calpains 1 and 2: a regulatory N-terminal domain (domain I),
protease domain (II, consisting of sub-domains IIa and IIb), C2-
like Ca
2+/phospholipid-binding domain (III), and penta-EF-hand
(PEF) domain (IV) (Figure 1A).
Although calpains 8 and 9 share this domain structure with
calpains 1 and 2, when expressed alone in cultured cells or E. coli,
calpain 8 is active without CAPNS1 and forms a homo-oligomer
[11], whereas calpain 9 requires the co-expression of CAPNS1
[12]. Possible functions for calpain 8 in vesicle trafficking between
the ER and Golgi, and those for its homologue, XCL-2, in the
PLoS Genetics | www.plosgenetics.org 1 July 2010 | Volume 6 | Issue 7 | e1001040embryogenesis of Xenopus laevis have been reported [13,14]. Down-
regulation of the calpain 9 transcript in a subset of gastric cancer
patients and gastric cancer cell lines [15], and the association of a
calpain 9 deficiency with the neoplastic transformation of naive
cells have been reported [16], suggesting that calpain 9 plays a
physiological role in the suppression of tumorigenesis.
These reports highlight that calpains 8 and 9 are regulated
differently from each other and also from the conventional
calpains, and thus have potentially important and specific
functions in the GI that cannot be compensated for by m-o rm -
calpain. However, calpains 8 and 9 have not been directly
implicated in GI diseases, and their molecular properties and
physiological functions have been elusive. To address these issues,
we generated and analyzed mice with mutations in the genes for
these calpains, Capn8 and Capn9. Our results provide genetic
evidence for the involvement of calpains 8 and 9 in gastric mucosal
defense. Gastric mucosal integrity depends on a complex defense
system that acts in the face of a variety of irritants, including
alcohol, nonsteroidal anti-inflammatory drugs (NSAIDs), and
Helicobacter pylori. The continuous or improper ingestion of these
irritants often leads to serious gastropathies [17,18]. Our results
might therefore contribute to the development of new therapeutic
strategies for human gastropathies induced by irritants.
Results
Capn8
2/2 and Capn9
2/2 mice are susceptible to
ethanol-induced gastric mucosal injury
We found that calpains 8 and 9 were predominantly expressed in
the stomach and, to a lesser extent, in the digestive tract (Figure 1B).
The gastric epithelium is continuously stressed by low pH and
digestive enzymes, and the pit cells play a central role in mucosal
protection by secreting neutral mucus and bicarbonate. The pit cells
originate from proliferative progenitor cells, which are located under
the pits and differentiate during theirmigration to the pits. Thesecells
undergo continuous turnover, being killed by apoptosis or necrosis
within a few days, to achieve homeostasis of the gastric mucosa [19].
The localization of calpains 8 and 9 overlapped, and was
predominant in the apical region of the non-proliferative middle
and top pit cells, as previously reported [13] (Figure 1C).
To examine the functions of these proteins, we generated
Capn8
2/2 and Capn9
2/2 mice (Figure 2A and 2B, Figure 3A and
3B), and confirmed the absence of their gene products by western blot
analysis (Figure 2C, Figure 3C, upper panels). The Capn8
2/2 and
Capn9
2/2 mice were fertile and showed no gross developmental
abnormalities. Histological analysis of the stomach and intestines
showed no obvious morphological abnormalities, such as mucosal
hypertrophy or myxasthenia (Figure 4A and 4B for the stomach).
To evaluate the effects of the calpain 8 or 9 deficiency on
stomach functions, we used an experimental gastric injury model.
Ethanol has long been used to generate a hemorrhagic gastric
mucosal injury in rodents [20]. Thus, we compared the
development of gastric mucosal injury after the oral administration
of ethanol among wild-type (WT), Capn8
2/2, and Capn9
2/2 mice.
The administration of 40% ethanol, which induced mild or little
gastric mucosal injury in WT mice (Figure 4C), caused
significantly enhanced gastric mucosal injuries in the Capn8
2/2
and Capn9
2/2 mice (Figure 4D). These mice showed no significant
difference under the control condition (0% ethanol), indicating
that calpains 8 and 9 are involved in protecting the gastric mucosa
from ethanol-induced lesions.
A complex network system functions to provide gastroprotection
against gastric injury, and includes mucous production/secretion,
andmucosalrestitution bythepit cells[21]. Toinvestigate the process
in which calpains 8 and 9 are involved, we examined the effect of the
calpain 8 or 9 deficiency on mucous granuleproduction and secretion
by electron microscopy and mucin immunostaining in the WT,
Capn8
2/2,a n dCapn9
2/2 mouse stomach. To monitor the early
response in the pit cells, the stomachs were examined before and
1 hour after the administration of 40% ethanol. Consistent with the
resultsshowninFigure4B,therewasnomarkeddifferenceingranule
formation among the WT, Capn8
2/2,a n dCapn9
2/2 mouse
stomachs before ethanol administration (Figure 5A, a–c). After the
administration, these mouse stomachs showed neither a marked
difference in appearance (Figure 5A, d–f) nor a significant difference
in granule numbers (Figure 5B). The expression pattern of mucin-
5AC (Muc5AC),a major component of the mucous secreted from the
p i tc e l l s ,d i dn o td i f f e rm a r k e d l ye i t h e r( F i g u r e5 C ) .T h e s er e s u l t s
indicated that calpains 8 and 9 do not function in granule production
or secretion, and suggested that they are probably involved in the
restitutionofthemucosabythepitcells.Furtherstudies,however,are
required to elucidate the function of calpains 8 and 9 in
gastroprotection.
Calpains 8 and 9 form a protease complex
The effect of Capn8
2/2 and Capn9
2/2 on other calpain
expressions was analyzed. Surprisingly, a significant decrease in
calpain 9 accompanied the loss of calpain 8 in Capn8
2/2 mice, and
similarly, calpain 8 was decreased in Capn9
2/2 mice; in contrast,
calpains 1 and 2 were unaltered in the mice of any genotype
(Figure 2C, Figure 3C). Consistent with these observations,
immunohistochemistry also showed that calpains 9 and 8
were both downregulated in the stomachs of Capn8
2/2 or
Capn9
2/2 mice (Figure 4E). Reverse transcribed-polymerase chain
reaction (RT-PCR) analysis showed that the calpain 8 transcript in
Capn9
+/2 and Capn9
2/2 mice and the calpain 9 transcript in
Capn8
+/2 and Capn8
2/2 mice were comparable to their level in
WT mice (Figure 6A), indicating that the observed down-
regulation was at the protein level. Immunoprecipitation using
lysate prepared from WT gastric mucosa co-precipitated calpains
8 and 9 (Figure 6B, lanes 2 and 5), whereas neither calpain 2 nor
Author Summary
The continuous or improper ingestion of irritants, includ-
ing alcohol, nonsteroidal anti-inflammatory drugs
(NSAIDs), and Helicobacter pylori, often leads to serious
gastropathies, affecting a wide range of people. A complex
gastric defense system helps protect against these threats,
for example by secreting mucus. Here we report that two
gastrointestinal-tract-specific calpains, calpain 8/nCL-2 and
calpain 9/nCL-4, are involved in the mucosal defense
against stress-induced gastropathies. Calpains are Ca
2+-
dependent cytosolic proteases that are indispensable for
various cellular processes. Improper calpain activities can
result in death or serious disorders, such as muscular
dystrophies and lissencephaly, although no role for
calpains in gastrointestinal diseases has been reported.
Here we show that mice with mutations in the genes for
calpains 8 and 9 are susceptible to alcohol-induced gastric
injury. Moreover, these calpains form a stable complex, in
which both molecules are essential for activity. Thus,
human calpains 8 and 9 may contribute to the stomach’s
susceptibility to stress caused by irritants such as alcohol.
Indeed, some reported human single nucleotide polymor-
phisms (SNPs) in these calpains are predicted to compro-
mise their proteolytic activity. Our mutant mice provide
unique animal models for potential human gastropathies
caused by such SNPs.
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observations indicated that calpains 8 and 9 form a complex in vivo.
To investigate the nature of this complex, homogenate prepared
from WT gastric mucosa was subjected to gel filtration column
chromatography. Western blot analysis of the fractions revealed
that calpains 8 and 9 were co-eluted with a single peak near the
177-kDa marker, whereas calpain 2 was eluted with a single peak
between the 67- and 177-kDa markers, which corresponds to the
molecular weight (MW) of m-calpain (calpain 2+CAPNS1,
110 kDa) (Figure 6C, WT). In contrast, in the homogenate from
the Capn8
2/2 gastric mucosa, calpain 9, at much lower levels than
in WT, showed an elution pattern similar to that of calpain 2
Figure 1. Calpains 8 and 9 showed the same tissue distribution and localization in the stomach. (A) Schematic illustrations of mammalian
calpains 1, 2, 8, and 9. Calpains 8 and 9 have a typical domain structure like calpains 1 and 2: a regulatory N-terminal pro-domain (domain I), protease
domain (subdomains IIa and IIb, also called subdomains I and II), C2-like Ca
2+/phospholipid-binding domain (domain III), and penta-EF-hand (PEF) domain
(domain IV). CAPNS1 includes a Glycine-rich domain (domain V) and PEF domain (domain VI). Calpain 8 shows high similarity to calpain 2 over the whole
molecule (amino acid identities of the full-length protein and of domains II and IV are 61.5%, 73.4%, and 51.8%, respectively). Calpain 1 (or 2) forms a
h e t e r o d i m e rw i t hC A P N S 1t ob em-calpain (or m-calpain). (B) Western blot analysis of mouse tissues using antibodies against calpain 8, calpain 9, calpain 1,
calpain 2,andb-actin. Twentymicrogramsoftissuehomogenate wasusedfor eachlaneexcept for b-actin, for which2 mgofhomogenate was used.Lanes:
1,gastric mucosa; 2,jejunum; 3,colon;4,spleen; 5,liver;6,kidney; 7, lung; 8,uterus; 9, heart;10, brain. Asterisksindicate non-specific signals originatingfrom
the secondary antibody. (C) Double-immunostaining of the mouse stomach was performed using antibodies against calpain 8 (red) and calpain 9 (green).
The right panel is a magnified view of the boxed area. Blue signals represent DAPI-stained nuclei. Bars, 50 mm.
doi:10.1371/journal.pgen.1001040.g001
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2/2’’), as did calpain 8 in the Capn9
2/2 gastric mucosa
(‘‘Capn9
2/2’’), indicating that the residual calpain 9 does not form
a homodimer without calpain 8, and vice versa.
Calpains 8 and 9 are molecular chaperones for each
other
Next, homogenate prepared from the Capn8
2/2 gastric mucosa
was incubated with or without Ca
2+. In WT mice, calpains 8 and 9
showed Ca
2+-dependent autolysis (Figure 6D, lanes 1 and 5),
which was inhibited by the addition of a recombinant calpastatin
domain 1 fragment, one of four inhibitory units of an endogenous
calpain-specific inhibitor protein, or of E64c, a more general
cysteine protease inhibitor (lanes 3, 4, 7, and 8). As seen for calpain
2i nCapns1
2/2 mouse embryos, which are deficient in CAPNS1
[22], the amount of calpain 9 in the Capn8
2/2 mice was
significantly decreased, as described above, and it lacked
proteolytic activity, even in the presence of Ca
2+ (lane 9).
Consistent with this finding, in transfected COS7 cells, calpains
8 and 9 were more abundant in the supernatant fraction when
both were co-expressed than when either molecule was expressed
singly (Figure 6E, lanes 3, 4, 7, and 8). These results indicated that
calpains 8 and 9 function as molecular chaperones for each other
in the complex, like CAPNS1 does for calpain 2.
Figure 2. Generation of Capn8
2/2 mice. (A) Schematic representation of the targeting vector and WT and knock-out (KO) alleles of mouse Capn8.
Exons 3 to 9 are indicated by black boxes with exon numbers. The probes for Southern blotting are shown as boxes with hatched lines. The PCR
primer positions for genotyping are shown by arrows. Neo, neomycin-resistance gene; DT-A, diphtheria toxin A fragment. (B) Southern blot (left) and
PCR (right) analyses of genomic DNA extracted from the tail of WT (+/+), Capn8
+/2 (+/2), and Capn8
2/2 (2/2) mice. The intercrossing of
heterozygous mice generated WT, heterozygous, and homozygous mice at a ratio not significantly different from the expected Mendelian ratio. M,
DNA marker. (C) Western blot analysis of gastric mucosal proteins prepared from WT (+/+), Capn8
+/2 (+/2), and Capn8
2/2 (2/2) littermate mice.
Twenty micrograms of sample was used for each lane. Asterisks indicate non-specific signals.
doi:10.1371/journal.pgen.1001040.g002
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defense
Recently, calpain 6, a unique non-proteolytic member of the
mammalian calpain family with a naturally inactive catalytic site,
was reported to interact with microtubules and microfilaments and
to be involved in their regulation [23]. Thus, calpain 6 is likely to
function as a structural element. To examine whether the calpain
8/9 complex functions as a structural component or protease, we
generated and analyzed calpain 8:C105S knock-in (Capn8
CS/CS)
mice, which express proteolytically inactive but structurally intact
calpain 8 (Figure 7A and 7B). Like the Capn8
2/2 mice, Capn8
CS/CS
mice were fertile with no apparent abnormalities. Notably, the
protein levels of calpains 8 and 9 as well as of calpains 1 and 2
were unaltered between the WT and Capn8
CS/CS mice (Figure 6C).
In the homogenate of the Capn8
CS/CS gastric mucosa, calpain 9
showed Ca
2+-dependent autolysis, which was inhibited by the
calpastatin domain 1 fragment or E64c (Figure 7D, lanes 13–16).
Notably, the calpain 8:C105S protein was almost completely
proteolyzed Ca
2+-dependently (Figure 7D, lane 5). This finding
strongly suggests that, in the calpain 8/9 complex, not only
Figure 3. Generation of Capn9
2/2 mice. (A) Schematic representation of the targeting vector and WT and knock-out (KO) alleles of mouse Capn9.
Exons 2 to 9 are indicated by black boxes with exon numbers. The probes for Southern blotting are shown as boxes with hatched lines. The PCR
primer positions for genotyping are shown by arrows. Neo, neomycin-resistance gene; DT-A, diphtheria toxin A fragment. (B) Southern blot (left) and
PCR (right) analyses of genomic DNA extracted from the tail of WT (+/+), Capn9
+/2 (+/2), and Capn9
2/2 (2/2) mice. Intercrossing of heterozygous
mice generated WT, heterozygous, and homozygous mice at a ratio not significantly different from the expected Mendelian ratio. M, DNA marker. (C)
Western blot analysis of gastric mucosal proteins prepared from WT (+/+), Capn9
+/2 (+/2), and Capn9
2/2 (2/2) mice. Twenty micrograms of sample
was used for each lane. Asterisks indicate non-specific signals.
doi:10.1371/journal.pgen.1001040.g003
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PLoS Genetics | www.plosgenetics.org 5 July 2010 | Volume 6 | Issue 7 | e1001040Figure 4. Capn8 or Capn9 deficiency increased the susceptibility to ethanol-induced gastric lesions. (A,B) The gastric mucosa of Capn8
2/2,
Capn9
2/2, and WT mice was sectioned and analyzed by hematoxylin-eosin (H-E) staining (A), and periodic acid-Schiff (PAS) staining (B). Bars, 100 mm. (C)
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place, as in the activation of m- and m-calpains, which involves the
proteolysis of CAPNS1 [2]. At present, it cannot be completely
excluded that m- and/or m-calpain in the same fraction
proteolyzed the calpain 8:C105S protein.
To our surprise, the oral administration of 40% ethanol
significantly induced gastric injury in Capn8
CS/CS mice
(Figure 7E), with a severity comparable to that in Capn8
2/2 and
Capn9
2/2 mice. This result indicated that the proteolytic activity
of calpain 8 is essential for gastric mucosal defense, even though
inactive calpain 8 forms a stable complex containing proteolyti-
cally active calpain 9.
Discussion
The functions of tissue-specific calpains are most likely
relevant to the tissues expressing them; therefore, there is an
advantage to studying them over ubiquitous calpains, which are
indispensable in embryogenesis or show functional redundancy
[22,24,25]. For example, skeletal muscle-specific calpain 3/p94
i sap r o d u c to ft h eg e n er e s p o n s i ble for limb-girdle muscular
dystrophy type 2A (LGMD2A) [4], demonstrating that the
inactivation of tissue-specific calpains is a potential direct
strategy for understanding some of the calpain functions. In
this study, we investigated the gastrointestinal-tract-specific
calpains by using gene targeting in mice, and obtained evidence
that calpains 8 and 9 play a protective role in the gastric mucosa
b yf o r m i n gap r o t e a s ec o m p l e x .T h i si st h ef i r s tr e p o r to ft h ein
vivo significance and properties of the gastrointestinal-tract-
specific calpains.
The ethanol stress-dependent phenotype of the Capn8
2/2 and
Capn9
2/2 mice and limited localization of calpains 8 and 9 suggest
that these mutant mice have mild defects in their pit cells, and/or
in their stress-induced immediate response for mucosal protection.
Figure 5. Effect of calpain 8 or 9 deficiency on mucous granule formation and secretion. (A) Electron micrographs of the pit cells of WT,
Capn8
2/2, and Capn9
2/2 mice before (a–c) and after (d–f) ethanol administration. The gastric lumen is at the top of each photograph. MG, mucous
granule; N, nuclei. Bars, 2 mm. (B) Comparison of the number of mucous granules per pit cell for WT, Capn8
2/2, and Capn9
2/2 mice before (white
bars) and after (black bars) ethanol administration. Top-pit (fully differentiated) cells randomly selected from stomach samples were analyzed for each
experimental group (n=45, 41, and 44 for the WT, Capn8
2/2, and Capn9
2/2 mouse stomach groups before ethanol administration, and n=36, 41,
and 42 for those groups after the administration, respectively). The sum of the mucous granules divided by the number of cells analyzed was defined
as the average number of granules per cell. Each mean value was standardized to that for the WT group before ethanol administration, which was
defined as 100%. Values are means 6 SEM. (C) Immunostaining of WT, Capn8
2/2, and Capn9
2/2 mouse stomachs before (a–c) and after (d–f) ethanol
administration using an antibody for Muc5AC (green). Bars, 50 mm.
doi:10.1371/journal.pgen.1001040.g005
Susceptibility of WT mice to ethanol-induced gastric lesions. The indicated concentrations of ethanol were orally administered to WT mice, and the lesion
index was determined (see Materials and Methods). Values are the means 6 standard error (SEM). (n=5). (D) (left) WT, Capn8
2/2,a n dCapn9
2/2 mice were
orally given 0% (white bars) or 40% (black bars) ethanol, and the lesion indexes were determined (see Materials and Methods). Values are means 6 SEM. *,
P,0.01 vs. WT; **, P,0.05 vs. WT; Not significant vs. Capn8
2/2 mice (***), and vs. WT (****). (right) Representative macroscopic views of the gastric mucosa
of each mouse 4 hours after 40% ethanol administration are shown. Bars, 5 mm. (E) The gastric mucosa of Capn8
2/2, Capn9
2/2, and WT mice was
sectioned and analyzed by immunostaining using antibodies for calpain 8 (red) and calpain 9 (green). Bars, 100 mm.
doi:10.1371/journal.pgen.1001040.g004
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blood flow have been reported to be important for gastric mucosal
protection and restitution [26–28]. Notably, here we found that
calpains 8 and 9 are also important for these functions,
illuminating a novel research area for gastroenterology.
It is striking that calpains 8 and 9 form a complex in which both
proteins are essential for stability and activity. This finding
explains the co-localization of calpains 8 and 9 in the stomach, and
why Capn8
2/2 and Capn9
2/2 mice showed the same phenotype
without functional compensation between calpains 8 and 9. The
Figure 6. Calpains 8 and 9 form a complex. (A) RT-PCR analysis of calpains 8 and 9 mRNA in the WT, Capn8
+/2, Capn8
2/2, Capn9
+/2, and
Capn9
2/2 gastric mucosa using primer pairs: calpain 8-59/-39 for calpain 8, calpain 9-59/-39 for calpain 9, and b-actin-59/-39 (see Table 2). (B) Gastric
mucosal homogenate was immunoprecipitated without (lane 3) or with anti-calpain 8 (lane 2), anti-calpain 9 (lane 5), or absorbed-anti-calpain 9 (lane
6) antibodies, and subjected to western blotting using anti-calpain 8, anti-calpain 9, or anti-m-calpain (for calpain 2 and CAPNS1) antibodies. Lanes 1
and 4, 2% of the input used for immunoprecipitation. (C) Elution profile of the gastric mucosal proteins of WT, Capn8
2/2, and Capn9
2/2 mice from a
Superdex 200 gel filtration column (solid line, A280). Fractions were subjected to western blotting using anti-calpain 8, anti-calpain 9, or anti-calpain 2
antibodies (lower panels). Asterisks indicate non-specific signals. (D) Gastric mucosal homogenates from WT (lanes 1–8) and Capn8
2/2 (lanes 9–12)
mice were incubated with or without Ca
2+ and inhibitors (CSTN, recombinant human calpastatin domain 1 fragment; E64, E64c). The samples were
subjected to western blotting using anti-calpain 8 (lanes 1–4) or anti-calpain 9 (lanes 5–12) antibodies. Open arrowheads and asterisks indicate
proteolytic fragments of calpain 9 and non-specific signals, respectively. (E) Mouse calpain 8 (lanes 1–4) was co-expressed with empty vector (lanes1
and 3) or mouse calpain 9 (lanes 2 and 4) in COS7 cells, and mouse calpain 9 (lanes 5–8) was co-expressed with empty vector (lanes 5 and 7) or mouse
calpain 8 (lanes 6 and 8). Soluble lysates (sup) were recovered by ultracentrifugation of the total lysates (total) of the treated COS7 cells. The same
amounts of lysate were subjected to western blot analysis using anti-calpain 8 (lanes 1–4) or anti-calpain 9 (lanes 5–8) antibodies.
doi:10.1371/journal.pgen.1001040.g006
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PLoS Genetics | www.plosgenetics.org 8 July 2010 | Volume 6 | Issue 7 | e1001040Figure 7. Capn8
CS/CS mice are susceptible to ethanol-induced mucosal lesions. (A) Schematic representation of the targeting vector and WT,
CS-neo, and CS alleles of mouse Capn8. Exons 3 to 7 are indicated by black boxes with exon numbers. The 39-probe for Southern blotting is shown as
a box with hatched lines. The PCR primer positions for the genotyping of Cre-recombinant mice are shown by arrows. Neo, neomycin-resistance
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one molecule each of calpain 8 and 9, although the possibility of
one or more small additional subunits cannot be eliminated. It is
curious that only calpains 8 and 9 form this complex, despite the
highly similar overall amino acid sequences among calpain 1,
calpain 2, calpain 8, and calpain 9. Recently, a comparison of the
3D structures of calpain 1, calpain 2, and calpain 9 revealed
divergent mechanisms for their activation and regulation [29].
Calpains 8 and 9 probably evolved to have local structures specific
for binding each other. We propose calling the enzyme entity
composed of calpains 8 and 9 in the stomach, ‘‘Gastric calpain’’
(‘‘G-calpain’’), a novel ‘‘hybrid’’ type of calpain enzyme composed
of different calpain catalytic subunits, which has never been
reported for any kind of calpain.
As shown in Table 1, in the NCBI single nucleotide
polymorphism (SNP) database, 3 and 15 missense polymorphisms
in calpains 8 and 9 were found, respectively. Among these SNPs,
the calpain 8:A136V, calpain 9:A102V, and calpain 9:R277W
polymorphisms represent changes in amino acid residues that are
highly conserved among calpain family members. Moreover, the
amino acid positions of calpain 8:A136 and calpain 9:R277
correspond to calpain 3:A160 and calpain 3:R357, respectively,
the sites of the reported LGMD2A pathogenic mutations, calpain
3:A160Q/P and calpain 3:R357W. These findings strongly
suggest that some of these SNPs compromise the proteolytic
activity of calpain 8 or calpain 9. Frame-shift SNPs are also
expected to drastically change the nature of calpain 9 by
truncating the C-terminal EF-hand motif(s). Therefore, it is
tempting to speculate that these SNPs are related to a susceptibility
to human gastropathies caused by irritants such as alcohol. It
should be noted that R277W SNP shows a global frequency of
0.006, which means that one out of every 28,000 people probably
has only inactive calpain 9 due to homozygous R277W alleles.
What is the physiological significance of the calpain 8/9
complex formation? Capn8
CS/CS mice, in which the calpain 9
protein level and proteolytic activity were unaltered, also showed a
susceptibility to ethanol-induced gastric injury. This finding
indicates that the activity of calpain 9 alone and inactive calpain
8 with its proteolyzed fragments were insufficient for specific
functions of the gastric pit cells, and leads to a new model for
calpain activation in the G-calpain system (Figure 8). In this
model, increased intracellular Ca
2+ induces the activation of
calpains 8 and 9 at the same time and location, which is
specifically required for pit-cell function, in addition to the
conventional calpain system. Identification of the in vivo substrates
for G-calpain is an important issue for future research. In this
regard, one promising candidate is b-COP [30,31], a subunit of
the COP-I vesicle coatomer complex, which is involved in Golgi-
endoplasmic reticulum membrane trafficking. We previously
identified b-COP as an in vitro substrate for calpain 8 [13]. On
the other hand, we also showed that G-calpain is not involved in
mucus production or secretion (see Figure 5), which suggested that
G-calpain functions in the mucosal restitution by pit cells after
gastric injury. Consistent with this idea, conventional calpains are
involved in cell migration [32]. Whether or not b-COP is relevant
to this process is a very important issue to be elucidated in the
future.
In humans, mutations of CAPN3 were shown to be responsible
for muscular dystrophy by forward genetics [4], and an intron
polymorphism of CAPN10 was reported to be associated with type
2 diabetes by statistical genetics [3]. This is the first report in which
disease-responsible calpain genes were identified by reverse
genetics. Our results also identify CAPN8 and CAPN9 as promising
targets for various stress-induced human gastropathies. Our
mutant mice described here represent potentially helpful tools
for studying such diseases.
Materials and Methods
Experimental animals
All procedures using experimental animals were approved by
the Experimental Animal Care and Use Committee of Rinshoken,
and the animals were treated according to the committee’s
guidelines. C57BL/6 and ICR mice were purchased from Nihon
CLEA. EIIa-Cre transgenic mice [33] were purchased from the
Jackson Laboratory.
Homologous recombination of embryonic stem (ES) cells
Mouse BAC clones containing Capn8 or Capn9 were purchased
from Children’s Hospital Oakland Research Institute. The
genomic fragments used were amplified by PCR using Phusion
high fidelity DNA polymerase (Finnzymes). Targeting vectors for
Capn8
2/2 and Capn9
2/2 mice were constructed by replacing exon
3, which includes the codon for the active-site residue Cys, with a
neomycin-resistance gene (neo) cassette (Figure 2A, Figure 3A).
For the calpain 8:C105S knock-in (Capn8
CS/CS) mice, Cys105 of
calpain 8 was mutated to serine (Cys105Ser). A neo cassette
flanked by loxP was inserted at intron 2 (Figure 7A). For the
Capn8
2/2 mice, a 3.2-kbp fragment containing intron 2, and a
6.8-kbp fragment containing exons 4 to 8 were amplified and used
as the 59-arm and 39-arm, respectively. For the Capn9
2/2 mice, a
4.2-kbp fragment containing exon 2, and an 8.6-kbp fragment
containing exons 4 to 7 were used. For the Capn8
CS/CS mice, a 4.3-
kbp fragment containing intron 2, and a 2.1-kbp fragment
containing exons 3 to 5 were used. For negative selection, a
diphtheria toxin A fragment with an MC1 promoter [34] was
attached downstream of the 39 arms. The targeting vectors for
Capn8
2/2 and Capn9
2/2 mice were linearized using SalI and
electroporated into the C57BL/6N-derived ES cell line, RENKA
[35]. For the Capn8
CS/CS mice, the targeting vector was linearized
using NotI and electroporated into TT2 ES cells [36]. The G418-
resistant clones were screened, and the correctly targeted clones
were confirmed by Southern blotting (Figure 2B, Figure 3B,
Figure 7B). For Southern blotting, genomic DNA was digested
with the appropriate restriction enzymes, and hybridized with the
32P-labeled probes shown in Figure 2A, Figure 3A, and Figure 7A.
gene; DT-A, diphtheria toxin A fragment. (B) (left) Southern blot analysis of genomic DNA extracted from the tail of WT, Capn8
CSneo/+ (CSneo/+), and
Capn8
CSneo/CSneo (CSneo/CSneo) mice. (right) PCR analysis of genomic DNA extracted from the tail of WT (+/+), Capn8
CS/+ (CS/+), and Capn8
CS/CS (CS/
CS) mice. Intercrossing of heterozygous mice generated wild-type, heterozygous, and homozygous mice at a ratio not significantly different from the
expected Mendelian ratio. M, DNA marker. (C) Western blot analysis of the gastric mucosal homogenates (20 mg) prepared from WT and Capn8
CS/CS
(CS/CS) mice. (D) The gastric mucosal homogenates from WT (lanes 1–4 and 9–12) and Capn8
CS/CS (lanes 5–8 and 13–16) mice were incubated with or
without Ca
2+ and inhibitors, as indicated (CSTN, recombinant human calpastatin domain 1 fragment; E64, E64c). The samples were subjected to
western blot analysis using an anti-calpain 8 (lanes 1–8) or anti-calpain 9 (lanes 9–16) antibody. Open arrowheads and asterisks indicate proteolytic
fragments of calpain 9 and non-specific signals, respectively. (E) (left) WT and Capn8
CS/CS mice were orally given 40% ethanol, and the lesion index
was determined. Values are the means 6 SEM. *, P,0.05 vs. WT. (right) Representative macroscopic views of the gastric mucosa of WT and Capn8
CS/CS
mice 4 hours after ethanol administration. Bars, 5 mm.
doi:10.1371/journal.pgen.1001040.g007
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2/2, Capn9
2/2, and Capn8
CS/CS mice
The generation of chimeric males was achieved by the
aggregation method for the Capn8
2/2 and Capn9
2/2 mice, and
by the injection method for the Capn8
CS/CS knock-in mice [36,37].
Briefly, 8-cell-stage embryos were flushed out of the fallopian tubes
of ICR females. In the aggregation method, the embryos were
treated with acid Tyrode’s buffer (Sigma) to remove the zona
pellucida, and each embryo was placed in a depression created by
an aggregation needle (Biological Laboratory Equipment) in a 35-
mm-diameter culture dish containing M16 medium (Sigma). Five
to ten positive ES cells were then placed adjacent to each embryo
in the depression. In the injection method, five to ten positive ES
cells were injected into each 8-cell-stage embryo. After an
overnight culture, the ES cell-containing embryos that developed
to the blastocyst stage were transplanted into the uterus of pseudo-
pregnant ICR females. Germline transmitted chimeric males were
Table 1. Missense SNPs in human CAPN8 and CAPN9 and related LGMD2A pathogenic mutations in CAPN3.
calpain SNPs
*1 domain
Allele frequency (No. in
parentheses: chromosome
sample count)
*2
Conser-
vation
*3 LGMD2A
*4 Note
calpain 8
(NP_001137434)
A136V IIa N.D. 11/14 A160Q, A160P
S245Y IIb N.D. 3/14
Q386fs:PVQNPFG* IIb N.D. -
calpain 9
(NP_006606)
A102V IIa global (178): 0.017, European (120)
African American (124), [unknown] (120): 0
Sub-Saharan African (120), Asian (178): 0.078
13/14 Next to A133V A133 of calpain 3 is
also well conserved
(11/14).
S122R IIa global (180): 0.100, multiple (68): 0.074
[unknown] (118): 0.102, European (118): 0.136
African American (122): 0.172
Sub-Saharan African (120): 0.233
Asian (180): 0.067
8/14
D164N IIa global (180): 0.006 1/14
I234T IIb global (172): 0.006, multiple (76): 0.013 6/14
A239T IIb global (180): 0.006, multiple (78): 0.013 4/14
R277W IIb global (178): 0.006 11/14 R357W
K322Q IIb global (178): 0.270, multiple (78): 0.282
[unknown] (52): 0.308, European (356): 0.267
African American (258): 0.340
Sub-Saharan African (356): 0.419
Caucasian (92): 0.360, Asian (872): 0.177
1/14
H327Q IIb global (178): 0.034, multiple (78): 0.038
Sub-Saharan African (120): 0.200
European (120): 0, Asian (180): 0
5/14
E342K IIb/III global (180): 0.039, multiple (78): 0.064
[unknown] (120): 0.017, European (408): 0
African American (170): 0.088
Sub-Saharan African (360): 0.158
Asian (588): 0
2/14
R458W III global (166): 0.006 8/14
L468R III multiple (78): 0.013 3/14
R522W IV global (178): 0.197, multiple (72): 0.181
[unknown] (118): 0.186
European (408): 0.157, Asian (654): 0.072
Sub-Saharan African (356): 0.250
African American (166): 0.356
1/9
K553fs:RTSNSRS* IV N.D. - Deletion of 2nd to
5th EF-hand motifs
M611I IV global (178): 0.056, multiple (76): 0.079
[unknown] (120): 0.017, European (408): 0
African American (170): 0.259
Sub-Saharan African (360): 0.192
Asian (588): 0
4/9
K673fs:GVHSSQYK* IV N.D. - Deletion of 5th EF-
hand motif
*1From the NCBI SNP database: http://www.ncbi.nlm.nih.gov/SNP/.
*2Multiple data were combined to obtain the total ratio.
*3Domains IIa and IIb of human CAPN1–3, 5–14, and SOLH, domain III of human CAPN1–3, 5–9,11–14, and CAPN10 (two domains), and domain IV of human CAPN1–3,
8–9, 11–14 were compared, and identical residues were counted.
*4From the Leiden Muscular Dystrophy database: http://www.dmd.nl/capn3_home.html. The residue numbers correspond to that of calpain 3/p94 (NP_000061).
doi:10.1371/journal.pgen.1001040.t001
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2/2 and Capn9
2/2
mice, and with C57BL/6J females for the calpain 8 CS knock-in
mice, to generate heterozygotes. For the Capn8
CS/CS mice, the
heterozygotes were crossed with EIIa-Cre transgenic mice, in
which Cre recombinase is expressed from the zygote stage, to
remove the neo cassette from intron 2. The resultant mice were
then backcrossed with C57BL/6J mice for 10 generations. The
PCR primers used for genotyping are listed in Table 2. The mice
were housed in pathogen-free facilities at our institute.
Antibodies and reagents
The anti-calpain 8 domain III polyclonal antibody (ab28215), anti-
calpain 9 monoclonal antibody (3A6), anti-calpain 9 polyclonal
antibody (V-18), anti-Muc5AC monoclonal antibody (clone 45M1),
and anti-b-actin monoclonal antibody (clone AC-15) were purchased
from Abcam, Abnova, Santa Cruz, Thermo Scientific, and Sigma,
respectively.The anti-calpain2 monoclonal antibody (4B9F1),anti-m-
calpain polyclonal antibody, and anti-calpain 1 polyclonal antibody
were kind gifts from Dr. Seiichi Kawashima, Dr. Hideo Sugita, and
Dr. Gen Kudo, respectively. Protease inhibitors (a recombinant
human calpastatin domain 1 fragment (TaKaRa, No. 7316), E64c,
PMSF, and pepstatin A) and chemical reagents were purchased from
TaKaRa, Peptide Institute, Sigma, and Kanto Chemical.
Histological analysis
Stomach and intestine samples were fixed and immunostained
as described previously [13], and the signals were detected by
LSM510 META confocal microscopy (Zeiss). For H-E staining,
the sections were stained with Mayer’s hematoxylin, followed by
eosin staining. For PAS staining, the sections were pre-treated with
0.5% periodic acid and stained with Schiff’s reagent (Polysciences).
H-E- and PAS-stained sections were mounted with Mount-Quick
(Daido Sangyo), and viewed with a BX60 microscope (Olympus).
The gastric ulcerogenic response was examined as described
previously, with some modifications [38,39]. Mice were fasted for
Figure 8. Hypothetical scheme for calpain activation in the stomach pit cells. (Upper) In the stomach pit cells, in addition to the
conventional m- and m-calpains, G-calpain is predominantly expressed. To be activated by Ca
2+, G-calpain requires both catalytic subunits, which
intramolecularly and intermolecularly autolyze, probably dissociating from each other. The proteolytic activity of at least calpain 8 is essential for the
physiological function of G-calpain, that is, stress-induced gastric mucosal protection. We previously found that calpain 8, when transiently expressed
without calpain 9 in cultured cells or in E. coli, forms homo-oligomers [11]. Although the physiological significance of this homo-oligomerization is
unclear, it may play a role in modulating the activation of G-calpain under certain conditions. (Lower) In contrast, conventional m- and m-calpains
require a regulatory subunit, CAPNS1, but not other catalytic subunits, to be Ca
2+-dependently activated to proteolyze their substrates, although it
remains controversial whether or not their activation involves the dissociation of subunits, as illustrated here [40–42]. Since the stomach is under
frequent stress, an extra calpain system in addition to the conventional one may have been required to respond swiftly to stresses.
doi:10.1371/journal.pgen.1001040.g008
Table 2. PCR primers used in this study.
Capn8KO-59 59-gcctaagctgaatgtgtgtgcacttc-39
Capn8KO-39 59-aacttggctgcgcttccagagtttct-39
Capn9KO-59 59-cagggatccctgtgtctgaaaccagtc-39
Capn9KO-39 59-ggaagatacccacatggtgtgacacca-39
Capn8CS-59 59-taggagagtgctgtggtacctttggtcgac-39
Capn8CS-39 59-gaattcctgcgacagggttatgtataaaca-39
Calpain 8-59 59-tacagggatcttggaccaggctctgca-39
Calpain 8-39 59-cttctgcttcggctgcgtttgaga-39
Calpain 9-59 59-atgccttacctgcatcggtcc-39
Calpain 9-39 59-ggatttggaagttctcagccacac-39
b-actin-59 59-caggagatggccactgccgca-39
b-actin-39 59-tccttctgcatcctgtcagca-39
doi:10.1371/journal.pgen.1001040.t002
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water. The mice were given 5 ml/kg body weight of 40% ethanol
or water (0% ethanol) orally. After 4 hours, the mice were
sacrificed by cervical dislocation. The stomachs were removed,
opened along the grate curvature, and rinsed gently in PBS for the
macroscopic evaluation of gastric lesions. The severity of gastric
lesions was scored according to the following lesion index: 0=no
lesion; 1=punctuate lesion; 2=short linear ulcer (less than 2 mm);
3=medium linear ulcer (2–4 mm); 4=long linear ulcer (more
than 4 mm). The sum of the total scores divided by the number of
samples was defined as the mean lesion index.
To evaluate the involvement of calpains 8 and 9 in mucous
formation and secretion, six experimental groups were prepared,
corresponding to WT, Capn8
2/2, and Capn9
2/2 mice before or
after 40% ethanol administration. Two mice were used for each
experimental group. The mice were sacrificed 1 hour after ethanol
administration, and stomach samples were prepared as described
above, and subjected to electron microscopy and immunostaining.
For electron microscopy, the stomach samples were fixed with
0.1 M sodium phosphate buffer (pH 7.4) containing 4% parafor-
maldehyde and 1% glutaraldehyde. After a 2-hour fixation at 4uC,
the samples were washed with 0.1 M sodium phosphate buffer
(pH 7.4), post-fixed in the same buffer containing 1% osmium
tetroxide for 60 min, dehydrated with a graded ethanol series, and
embedded in Epon 812 (Shell Chemicals). Semi-thin sections
stained with toluidine blue were prepared, to verify the orientation
of the sections by light microscopy. Ultra-thin sections were then
prepared and mounted on copper grids, electron-stained with
uranyl acetate and lead citrate, and examined with a JEM 1230
electron microscope (Japan Electron Optics Laboratory) at an
accelerating voltage of 80 kV.
Biochemical analyses
Mouse gastric mucosa was scraped from the underlying
muscularis layer, homogenized in the appropriate buffer, and
subjected to immunoprecipitation, incubation assay, or gel-
filtration analyses. For immunoprecipitation, the gastric mucosal
homogenate from a WT, Capn8
2/2,o rCapn9
2/2 mouse in lysis
buffer (10 mM Tris/Cl (pH 7.5), 5 mM EDTA, 150 mM NaCl,
0.5% NP-40, 0.2 mM PMSF, 5 mM pepstatin A, and 25 mM
leupeptin) was prepared and immunoprecipitated with or without
an anti-calpain 8 antibody, anti-calpain 9 (V-18) antibody, or
antigen absorbed-anti-calpain 9 (V-18) antibody for 16 hours at
4uC, followed by the addition of protein G. After the bound
protein G was washed five times with the lysis buffer, the
immunoprecipitated proteins were eluted with 0.2 M Glycine
(pH 2.7) and mixed with SDS sample buffer. For the incubation
assay, the gastric mucosal homogenate from a WT, Capn8
2/2,o r
Capn8
CS/CS mouse was prepared in TED buffer (10 mM Tris/Cl
(pH 7.5), 1 mM EDTA, 1 mM dithiothreitol) containing 0.2 mM
PMSF and 5 mM pepstatin A. The homogenate (20 mg) was
incubated at 30uC for 30 min in the absence or presence of 5 mM
Ca
2+ with or without 6 mM recombinant human calpastatin
domain 1 fragment or 80 mM E64c. The reaction was stopped by
adding SDS sample buffer. The protein samples were subjected to
Western blot analysis with the appropriate antibodies. For the gel
filtration analysis, the gastric mucosal homogenate from a WT,
Capn8
2/2,o rCapn9
2/2 mouse was prepared in TED buffer
containing 0.2 mM PMSF, 5 mM pepstatin A, and 25 mM
leupeptin. The homogenate (1 mg) was applied to a Superdex
200 10/30 column (GE Healthcare) equilibrated with elution
buffer (150 mM NaCl in TED buffer). COS7 cells were
transfected by electroporation, as described previously [13].
RT–PCR
For RT-PCR analysis, the total RNAs were extracted from the
gastric mucosa of WT, Capn8
+/2, Capn8
2/2, Capn9
+/2, and
Capn9
2/2 mice using a TRIzol reagent (Invitrogen), reverse-
transcribed to make the first-strand cDNA, using a First Strand
cDNA Synthesis kit (Amersham Bioscience) according to the
manufacturer’s instructions, and subjected to PCR using ExTaq
(TaKaRa). Mouse b-actin was used as an internal control. The
primers used are listed in Table 2.
Statistical analysis
Differences between two mean values were analyzed by
Student’s t-test, and P values,0.05 were defined as statistically
significant.
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